September 2018 plab 1 recall-PHARMACOLOGY

PHARMACOLOGY

 Morphine cannot be taken orally as patient is confused so change it to subcutaneous with
half dose
 Morphine dose breakthrough question in which oral dose became too excessive and there
was signs of obstruction so it was changed to subcutaneous route
 Morphine to pain management in thigh with radiotherapy
 Amitryptyline toxicity so investigation was ECG
 Clarithromycin started so the next step was to uphold simvastatin
 Neutropenic sepsis in which if IV antifungals are to be added with antibiotics